Analysts Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) PT at $70.22

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the nine research firms that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $70.22.

ACHC has been the topic of a number of recent analyst reports. KeyCorp upgraded shares of Acadia Healthcare from a "sector weight" rating to an "overweight" rating and set a $70.00 price target on the stock in a report on Tuesday, January 7th. Cantor Fitzgerald reiterated a "neutral" rating and set a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Barclays decreased their price target on Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating for the company in a research note on Friday, November 22nd. Royal Bank of Canada reaffirmed an "outperform" rating and set a $64.00 price objective on shares of Acadia Healthcare in a research report on Friday, January 10th. Finally, TD Cowen decreased their target price on Acadia Healthcare from $70.00 to $66.00 and set a "buy" rating for the company in a research report on Tuesday, January 7th.

Acadia Healthcare Stock Down 0.7 %

Shares of ACHC traded down $0.32 during mid-day trading on Tuesday, reaching $44.18. The company had a trading volume of 1,204,528 shares, compared to its average volume of 1,929,001. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company has a market capitalization of $4.10 billion, a price-to-earnings ratio of 14.49, a price-to-earnings-growth ratio of 1.79 and a beta of 1.29. The firm has a 50-day moving average price of $41.03 and a 200 day moving average price of $56.58. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million for the quarter, compared to analysts' expectations of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The company's quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.91 earnings per share. On average, sell-side analysts forecast that Acadia Healthcare will post 3.39 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Blue Trust Inc. lifted its position in Acadia Healthcare by 69.4% during the fourth quarter. Blue Trust Inc. now owns 842 shares of the company's stock valued at $33,000 after purchasing an additional 345 shares in the last quarter. Nisa Investment Advisors LLC raised its stake in shares of Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock worth $41,000 after buying an additional 301 shares during the period. GAMMA Investing LLC grew its stake in shares of Acadia Healthcare by 57.1% during the 3rd quarter. GAMMA Investing LLC now owns 663 shares of the company's stock valued at $42,000 after acquiring an additional 241 shares during the period. Fifth Third Bancorp increased its holdings in Acadia Healthcare by 56.0% in the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock worth $50,000 after acquiring an additional 454 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in Acadia Healthcare during the second quarter valued at approximately $59,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.